Free Trial

Tactile Systems Technology (TCMD) Competitors

$12.78
-0.14 (-1.08%)
(As of 05/23/2024 ET)

TCMD vs. TMCI, INO, SKIN, SGHT, LUNG, TLSI, GUTS, CERS, NYXH, and OSUR

Should you be buying Tactile Systems Technology stock or one of its competitors? The main competitors of Tactile Systems Technology include Treace Medical Concepts (TMCI), Inovio Pharmaceuticals (INO), Beauty Health (SKIN), Sight Sciences (SGHT), Pulmonx (LUNG), TriSalus Life Sciences (TLSI), Fractyl Health (GUTS), Cerus (CERS), Nyxoah (NYXH), and OraSure Technologies (OSUR). These companies are all part of the "surgical & medical instruments" industry.

Tactile Systems Technology vs.

Treace Medical Concepts (NASDAQ:TMCI) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, community ranking, risk, valuation, earnings and dividends.

Treace Medical Concepts presently has a consensus target price of $12.21, suggesting a potential upside of 124.94%. Tactile Systems Technology has a consensus target price of $30.00, suggesting a potential upside of 133.83%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than Treace Medical Concepts.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tactile Systems Technology
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Tactile Systems Technology received 337 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 69.56% of users gave Tactile Systems Technology an outperform vote while only 53.33% of users gave Treace Medical Concepts an outperform vote.

CompanyUnderperformOutperform
Treace Medical ConceptsOutperform Votes
24
53.33%
Underperform Votes
21
46.67%
Tactile Systems TechnologyOutperform Votes
361
69.56%
Underperform Votes
158
30.44%

Tactile Systems Technology has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$187.12M1.78-$49.53M-$0.88-6.09
Tactile Systems Technology$274.42M1.11$28.51M$1.2010.71

In the previous week, Treace Medical Concepts had 6 more articles in the media than Tactile Systems Technology. MarketBeat recorded 11 mentions for Treace Medical Concepts and 5 mentions for Tactile Systems Technology. Treace Medical Concepts' average media sentiment score of 0.66 beat Tactile Systems Technology's score of 0.25 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Treace Medical Concepts
2 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tactile Systems Technology
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 1.0% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Treace Medical Concepts has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.

Tactile Systems Technology has a net margin of 10.19% compared to Tactile Systems Technology's net margin of -27.93%. Treace Medical Concepts' return on equity of 15.88% beat Tactile Systems Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-27.93% -39.66% -22.24%
Tactile Systems Technology 10.19%15.88%10.33%

Summary

Tactile Systems Technology beats Treace Medical Concepts on 14 of the 18 factors compared between the two stocks.

Get Tactile Systems Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCMD vs. The Competition

MetricTactile Systems TechnologySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$305.32M$3.86B$5.10B$8.05B
Dividend YieldN/A2.00%2.81%3.92%
P/E Ratio10.718.43123.7914.85
Price / Sales1.1171.242,506.4775.11
Price / Cash8.3747.9235.9531.80
Price / Book1.585.065.484.61
Net Income$28.51M$3.72M$105.62M$214.00M
7 Day Performance-5.93%-1.50%-1.39%-0.77%
1 Month Performance-11.81%1.02%2.67%3.18%
1 Year Performance-38.31%17.91%5.13%7.24%

Tactile Systems Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMCI
Treace Medical Concepts
3.3328 of 5 stars
$4.97
+0.6%
$12.21
+145.8%
-80.2%$308.18M$196.03M-5.65516Insider Buying
INO
Inovio Pharmaceuticals
3.751 of 5 stars
$10.99
-1.1%
$70.67
+543.0%
-88.4%$284.75M$830,000.000.00122Gap Up
SKIN
Beauty Health
2.9273 of 5 stars
$2.65
+2.3%
$6.29
+137.2%
-74.7%$327.08M$393.12M-3.79881Positive News
SGHT
Sight Sciences
0.3612 of 5 stars
$5.46
-3.7%
$4.70
-13.9%
-43.7%$271.67M$81.50M-4.87214
LUNG
Pulmonx
3.0506 of 5 stars
$8.78
-1.6%
$16.33
+86.0%
-29.0%$340.84M$68.68M-5.70279
TLSI
TriSalus Life Sciences
2.9012 of 5 stars
$9.97
-1.8%
$16.00
+60.5%
N/A$266.80M$18.51M0.00106Gap Down
GUTS
Fractyl Health
0 of 5 stars
$7.28
+4.4%
$22.00
+202.2%
N/A$348.71M$120,000.000.00102Gap Up
CERS
Cerus
2.8898 of 5 stars
$1.85
-5.1%
$3.83
+107.2%
-2.5%$360.54M$163.76M-10.88625Positive News
NYXH
Nyxoah
2.0743 of 5 stars
$10.00
flat
$20.20
+102.0%
+36.4%$249.40M$5.13M-6.10146Analyst Revision
News Coverage
OSUR
OraSure Technologies
3.8533 of 5 stars
$4.90
-0.6%
$6.63
+35.2%
-5.3%$362.40M$405.47M16.33638

Related Companies and Tools

This page (NASDAQ:TCMD) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners